Roberts Glore & Co. Inc. IL purchased a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 6,037 shares of the company’s stock, valued at approximately $776,000.
Other hedge funds have also recently added to or reduced their stakes in the company. Jupiter Topco LLC bought a new stake in shares of Merck KGaA during the second quarter valued at approximately $501,199,000. ADAR1 Capital Management LLC bought a new stake in Merck KGaA during the 2nd quarter valued at $403,000. EFG International AG acquired a new position in Merck KGaA during the second quarter worth $15,364,000. Ancora Advisors LLC bought a new position in shares of Merck KGaA in the second quarter valued at $2,686,000. Finally, Delos Wealth Advisors LLC bought a new position in shares of Merck KGaA in the second quarter valued at $33,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Stock Up 0.3%
Shares of OTCMKTS MKGAF opened at $164.00 on Wednesday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The company has a 50-day moving average price of $163.08 and a 200-day moving average price of $148.69. The stock has a market capitalization of $21.20 billion, a P/E ratio of 25.04 and a beta of 0.96. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
- Five stocks we like better than Merck KGaA
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
